While two prophylactic HPV vaccines have been proven notably efficacious in clinical trials,
the effectiveness of these vaccines at the population level remains to be evaluated. To lay …

… was conducted before human papillomavirus vaccine licensure and therefore focused on
a candidate quadrivalent human papillomavirus vaccine and a range of potential vaccination …

… of human papillomavirus (HPV) vaccination in low- and lower-middle income countries with
major disruptions to routine immunization and the introduction of new vaccines delayed. This …

… human papillomavirus (HPV) vaccine soon to become available for widespread use, several
studies have modelled the cost-effectiveness of vaccination… relating to vaccine effectiveness…

Cervical cancer is one of the most common cancers threatening women's health, and the
persistent infection of high-risk human papillomavirus (HPV) is closely related to the …

… effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine 2007;25:…
Assessing the introduction of universal human papillomavirus vaccination for preadolescent …

… Vaccination with human papillomavirus 9-valent or human papillomavirus quadrivalent
vaccine also protects against anogenital warts (90 percent of which are caused by HPV types 6 …

PROBLEM: Virtually all women who have cervical cancer are infected with the human
papillomavirus (HPV). Of the 275 000 women who die from cervical cancer every year, 88% live in …

… gains in human papillomavirus (HPV) vaccination coverage. HPV vaccine protects against
six … have worked tirelessly to establish the adolescent vaccine platform as part of routine care, …

… It is now evident that persistent infection with high-risk human papillomavirus (HPV) is
necessary for the development and maintenance of cervical cancer. Thus, effective vaccination …